PLUR
Price
$3.07
Change
-$0.17 (-5.25%)
Updated
Jan 14 closing price
Capitalization
28.41M
Intraday BUY SELL Signals
RLMD
Price
$3.84
Change
-$0.22 (-5.42%)
Updated
Jan 14 closing price
Capitalization
281.6M
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PLUR vs RLMD

Header iconPLUR vs RLMD Comparison
Open Charts PLUR vs RLMDBanner chart's image
Pluri
Price$3.07
Change-$0.17 (-5.25%)
Volume$1.19K
Capitalization28.41M
Relmada Therapeutics
Price$3.84
Change-$0.22 (-5.42%)
Volume$413.96K
Capitalization281.6M
PLUR vs RLMD Comparison Chart in %
PLUR
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PLUR vs. RLMD commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLUR is a Hold and RLMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (PLUR: $3.07 vs. RLMD: $3.84)
Brand notoriety: PLUR and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLUR: 2% vs. RLMD: 42%
Market capitalization -- PLUR: $28.41M vs. RLMD: $281.6M
PLUR [@Biotechnology] is valued at $28.41M. RLMD’s [@Biotechnology] market capitalization is $281.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLUR’s FA Score shows that 0 FA rating(s) are green whileRLMD’s FA Score has 0 green FA rating(s).

  • PLUR’s FA Score: 0 green, 5 red.
  • RLMD’s FA Score: 0 green, 5 red.
According to our system of comparison, RLMD is a better buy in the long-term than PLUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLUR’s TA Score shows that 4 TA indicator(s) are bullish while RLMD’s TA Score has 3 bullish TA indicator(s).

  • PLUR’s TA Score: 4 bullish, 2 bearish.
  • RLMD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PLUR is a better buy in the short-term than RLMD.

Price Growth

PLUR (@Biotechnology) experienced а +3.02% price change this week, while RLMD (@Biotechnology) price change was -11.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

RLMD is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLMD($282M) has a higher market cap than PLUR($28.4M). PLUR YTD gains are higher at: 2.676 vs. RLMD (-20.497). PLUR has higher annual earnings (EBITDA): -22.09M vs. RLMD (-57.84M). PLUR has more cash in the bank: 15.1M vs. RLMD (13.9M). RLMD has less debt than PLUR: RLMD (256K) vs PLUR (34.2M). PLUR has higher revenues than RLMD: PLUR (1.33M) vs RLMD (0).
PLURRLMDPLUR / RLMD
Capitalization28.4M282M10%
EBITDA-22.09M-57.84M38%
Gain YTD2.676-20.497-13%
P/E RatioN/AN/A-
Revenue1.33M0-
Total Cash15.1M13.9M109%
Total Debt34.2M256K13,359%
FUNDAMENTALS RATINGS
PLUR vs RLMD: Fundamental Ratings
PLUR
RLMD
OUTLOOK RATING
1..100
480
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RLMD's Valuation (71) in the null industry is in the same range as PLUR (95) in the Biotechnology industry. This means that RLMD’s stock grew similarly to PLUR’s over the last 12 months.

RLMD's Profit vs Risk Rating (100) in the null industry is in the same range as PLUR (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to PLUR’s over the last 12 months.

RLMD's SMR Rating (100) in the null industry is in the same range as PLUR (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to PLUR’s over the last 12 months.

RLMD's Price Growth Rating (34) in the null industry is in the same range as PLUR (64) in the Biotechnology industry. This means that RLMD’s stock grew similarly to PLUR’s over the last 12 months.

RLMD's P/E Growth Rating (100) in the null industry is in the same range as PLUR (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to PLUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLURRLMD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
PLUR
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLW90.210.33
+0.37%
Corning
FDBC42.990.16
+0.37%
Fidelity D & D Bancorp
OPRA13.45-0.02
-0.15%
Opera Limited
PI181.36-18.18
-9.11%
Impinj
CVV3.86-0.41
-9.60%
CVD Equipment Corp

PLUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLUR has been loosely correlated with RLMD. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PLUR jumps, then RLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLUR
1D Price
Change %
PLUR100%
-5.15%
RLMD - PLUR
37%
Loosely correlated
-5.42%
ENSC - PLUR
32%
Poorly correlated
+0.50%
ITRM - PLUR
29%
Poorly correlated
-2.98%
KOD - PLUR
29%
Poorly correlated
+1.24%
MGNX - PLUR
26%
Poorly correlated
+1.71%
More

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENSC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
-5.42%
ENSC - RLMD
41%
Loosely correlated
+0.50%
PLUR - RLMD
37%
Loosely correlated
-5.15%
SYRE - RLMD
36%
Loosely correlated
+5.17%
PRTC - RLMD
31%
Poorly correlated
+4.81%
AVXL - RLMD
31%
Poorly correlated
+3.88%
More